Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Erweiterte Suche bearbeiten
Filter bei nächster Suche beibehalten
publishDate:"[2019 TO 2021]"
collection:"CTG"
topic_facet:"Syndrome"
topic_facet:"Recruitment Status: Withdrawn"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=publishDate%3A%22%5B2019+TO+2021%5D%22&filter%5B%5D=collection%3A%22CTG%22&filter%5B%5D=topic_facet%3A%22Syndrome%22&filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Withdrawn%22&join=AND&bool0%5B%5D=AND&lookfor0%5B%5D=%22novel+coronavirus%22+OR+Covid+OR+%22Sars-CoV%22+OR+%22CoV-2%22+OR+ncov&type0%5B%5D=AllFields&op0%5B%5D=OR
/vufind/Search/Results?filter%5B%5D=publishDate%3A%22%5B2019+TO+2021%5D%22&filter%5B%5D=collection%3A%22CTG%22&filter%5B%5D=topic_facet%3A%22Syndrome%22&filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Withdrawn%22&join=AND&bool0%5B%5D=AND&lookfor0%5B%5D=%22novel+coronavirus%22+OR+Covid+OR+%22Sars-CoV%22+OR+%22CoV-2%22+OR+ncov&type0%5B%5D=AllFields&op0%5B%5D=OR
Search /vufind/Search2/Results?filter%5B%5D=publishDate%3A%22%5B2019+TO+2021%5D%22&filter%5B%5D=collection%3A%22CTG%22&filter%5B%5D=topic_facet%3A%22Syndrome%22&filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Withdrawn%22&join=AND&bool0%5B%5D=AND&lookfor0%5B%5D=%22novel+coronavirus%22+OR+Covid+OR+%22Sars-CoV%22+OR+%22CoV-2%22+OR+ncov&type0%5B%5D=AllFields&op0%5B%5D=OR
PubPharm (8)
1
Safety and Efficacy of Hydroxychloroquine for the Treatment & Prevention of Coronavirus Disease 2019 (COVID-19) Caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) : Safety and Efficacy of Hydroxychloroquine for the Treatment & Prevention of Coronavirus Disease 2019 (COVID-19) Caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
enthalten in:
ClinicalTrials.gov
| 2021
Wird geladen...
2
Tazemetostat for the Treatment of Moderate to Severe COVID-19 Infection : Repurposing Tazemetostat for the Treatment of Acute Respiratory Distress Syndrome (ARDS) or Systemic Cytokine Release Syndrome (SCRS) in COVID-19 Patient
enthalten in:
ClinicalTrials.gov
| 2021
Wird geladen...
3
Study of Allogeneic Adipose-Derived Mesenchymal Stem Cells for Non-COVID-19 Acute Respiratory Distress Syndrome : Treatment of Non-COVID-19 Acute Respiratory Distress Syndrome: A Phase 2 Study of the Efficacy and Safety of Intravenous Allogeneic Adipose-Derived Mesenchymal Stem Cells
enthalten in:
ClinicalTrials.gov
| 2021
Wird geladen...
4
Infusions of Mesenchymal Stromal Cells in Children With Multisystem Inflammatory Syndrome : A Phase I Pilot Study of the Safety of Infusions of Allogeneic Human Cord Tissue Mesenchymal Stromal Cells in Children With Multisystem Inflammatory Syndrome in Children (MIS-C)
enthalten in:
ClinicalTrials.gov
| 2021
Wird geladen...
5
Effects of mTOR Inhibition With Sirolimus (RAPA) in Patients With COVID-19 to Moderate the Progression of ARDS : Effects of mTOR Inhibition With Sirolimus (RAPA) in Patients With COVID-19 to Moderate the Progression of Acute Respiratory Distress Syndrome (RAPA-CARDS)
enthalten in:
ClinicalTrials.gov
| 2021
Wird geladen...
6
Safety of T Regulatory Cell Therapy in Subjects With COVID-19 Induced Acute Respiratory Distress Syndrome : A Phase 1 Study to Assess the Safety of Living Related Donor Derived T Regulatory Cell Therapy in Subjects With COVID 19 Induced Acute Respiratory Distress Syndrome (ARDS)
enthalten in:
ClinicalTrials.gov
| 2021
Wird geladen...
7
Metformin Glycinate in Patients With MS or DM2 , Hospitalized With COVID-19 and SARS Secondary to SARS-CoV-2 : Adaptive Study for Efficacy and Safety of Metformin Glycinate for the Treatment of Patients With MS and DM2, Hospitalized With Severe Acute Respiratory Syndrome Secondary to SARS-CoV-2. Randomized, Double-Blind, Phase IIIb.
enthalten in:
ClinicalTrials.gov
| 2021
Wird geladen...
8
Impact of Tissue Plasminogen Activator (tPA) Treatment for an Atypical Acute Respiratory Distress Syndrome (COVID-19) : Tissue Plasminogen Activator (tPA) Treatment for an Atypical Acute Respiratory Distress Syndrome (Microvascular COVID-19 Lung Vessels Obstructive Thromboinflammatory Syndrome (MicroCLOTS): A Multicentral Randomized Trial (AtTAC-trial)
enthalten in:
ClinicalTrials.gov
| 2021
Wird geladen...
1
[1]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Filter aufheben
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Erscheinungsjahr: 2019-2021
Filter aufheben
Thema: Syndrome
Filter aufheben
Thema: Recruitment Status: Withdrawn
Medienart
8
Aufsätze
8
E-Artikel
8
E-Ressourcen
Zeitschriftentitel
8
ClinicalTrials.gov
Thema
8
610
Recruitment Status: Withdrawn
8
Study Type: Interventional
Syndrome
5
Acute Lung Injury
5
Respiratory Distress Syndrome, Newborn
3
Phase: Phase 1
3
Phase: Phase 2
3
Respiratory Distress Syndrome, Adult
2
COVID-19
2
Respiratory Distress Syndrome
2
Severe Acute Respiratory Syndrome
1
Coronavirus Infections
1
Cytokine Release Syndrome
1
Diabetes Mellitus, Type 2
1
Lung Injury
1
Medical Condition: Acute Lung Injury/Acute Resp...
1
Medical Condition: Acute Respiratory Distress S...
1
Medical Condition: Acute Respiratory Distress S...
1
Medical Condition: Acute Respiratory Distress S...
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
2019-2021
Erscheinungsjahr(e)
Von:
Bis:
Sprache
8
Englisch
Haven't found what you're looking for?
Wird geladen...